Solid forms of dabigatran etexilate mesylate and processes for their preparation
EP2597096A1
Process for preparing entecavir and intermediates thereof
MX2013000294A
Intermediates and process for preparing a thrombin specific inhibitor.
MX2013000295A
Process of preparing a thrombin specific inhibitor.
CA2789298A1
Preparation process of the sodium salt of esomeprazole
EP2471783A1
Novel polymorphic form of efavirenz
EP2474548A1
Preparation process of an antiviral drug and intermediates thereof
EP2418192A1
Intermediates for the preparation of 1-aryl-pyrazol-3-one compounds useful as sigma receptors inhibitors
EP2377862A1
Process for obtaining emtricitabine
EP2348020A1
Preparation process of erlotinib
EP2314578A1
Cinchonidine salt of (4S,5S)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, useful as intermediate in the preparation of cannabinoid CB1 neutral antagonists
EP2272830A1
Preparation process of an antivirally heterocyclic azahexane derivative
EP2223923A1
Process for the preparation of a chiral beta aminoacid derivative and intermediates thereof
EP2085397A1
Crystalline form of abacavir
EP2072510A1
Crystalline form of azelastine
EP2079741A1
Process for the preparation of abacavir
EP2020403A1
Process for the resolution of zopiclone and intermediate compounds
EP1978014A1
Process for the preparation of entacapone and intermediates thereof